| 000 | 01910 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515020134.0 | ||
| 264 | 0 | _c20060801 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/j.lfs.2006.01.031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Hong-Wei | |
| 245 | 0 | 0 |
_aAngiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars. _h[electronic resource] |
| 260 |
_bLife sciences _cJun 2006 |
||
| 300 |
_a475-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCicatrix, Hypertrophic _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aPhosphotransferases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aReceptor Cross-Talk _xdrug effects |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 2 _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Angiotensin _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSkin _xcytology |
| 650 | 0 | 4 |
_aTranscriptional Activation _xgenetics |
| 700 | 1 | _aCheng, Biao | |
| 700 | 1 | _aYu, Wen-Lin | |
| 700 | 1 | _aSun, Rui-Xia | |
| 700 | 1 | _aZeng, Dong | |
| 700 | 1 | _aWang, Jie | |
| 700 | 1 | _aLiao, Yuan-Xing | |
| 700 | 1 | _aFu, Xiao-Bing | |
| 773 | 0 |
_tLife sciences _gvol. 79 _gno. 5 _gp. 475-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2006.01.031 _zAvailable from publisher's website |
| 999 |
_c16131976 _d16131976 |
||